Literature DB >> 25364021

Drug-Use Evaluation Comparing Dexmedetomidine Use at 3 Health Authority Sites Relative to Manufacturer's Recommended Directions (DECODE Study).

Krystin Boyce1, Edward C Dillon2, Jerrold Perrott3, Douglas L Malyuk3, Vincent Mabasa4, Emma Attfield5, Grant McCormack6, Sean Keenan7.   

Abstract

Entities:  

Year:  2014        PMID： 25364021      PMCID： PMC4214581          DOI： 10.4212/cjhp.v67i5.1393

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  10 in total

1.  Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials.

Authors:  Stephan M Jakob; Esko Ruokonen; R Michael Grounds; Toni Sarapohja; Chris Garratt; Stuart J Pocock; J Raymond Bratty; Jukka Takala
Journal:  JAMA       Date:  2012-03-21       Impact factor: 56.272

Review 2.  Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis.

Authors:  Jen A Tan; Kwok M Ho
Journal:  Intensive Care Med       Date:  2010-04-08       Impact factor: 17.440

3.  Delirium in an intensive care unit: a study of risk factors.

Authors:  M J Dubois; N Bergeron; M Dumont; S Dial; Y Skrobik
Journal:  Intensive Care Med       Date:  2001-08       Impact factor: 17.440

4.  The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation.

Authors:  M H Kollef; N T Levy; T S Ahrens; R Schaiff; D Prentice; G Sherman
Journal:  Chest       Date:  1998-08       Impact factor: 9.410

5.  Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit.

Authors:  E Wesley Ely; Ayumi Shintani; Brenda Truman; Theodore Speroff; Sharon M Gordon; Frank E Harrell; Sharon K Inouye; Gordon R Bernard; Robert S Dittus
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

6.  Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.

Authors:  Richard R Riker; Yahya Shehabi; Paula M Bokesch; Daniel Ceraso; Wayne Wisemandle; Firas Koura; Patrick Whitten; Benjamin D Margolis; Daniel W Byrne; E Wesley Ely; Marcelo G Rocha
Journal:  JAMA       Date:  2009-02-02       Impact factor: 56.272

Review 7.  An updated focused review of dexmedetomidine in adults.

Authors:  Anthony T Gerlach; Claire V Murphy; Joseph F Dasta
Journal:  Ann Pharmacother       Date:  2009-12       Impact factor: 3.154

8.  Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.

Authors:  Pratik P Pandharipande; Brenda T Pun; Daniel L Herr; Mervyn Maze; Timothy D Girard; Russell R Miller; Ayumi K Shintani; Jennifer L Thompson; James C Jackson; Stephen A Deppen; Renee A Stiles; Robert S Dittus; Gordon R Bernard; E Wesley Ely
Journal:  JAMA       Date:  2007-12-12       Impact factor: 56.272

9.  Use of intravenous infusion sedation among mechanically ventilated patients in the United States.

Authors:  Hannah Wunsch; Jeremy M Kahn; Andrew A Kramer; Gordon D Rubenfeld
Journal:  Crit Care Med       Date:  2009-12       Impact factor: 7.598

Review 10.  Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit.

Authors:  Juliana Barr; Gilles L Fraser; Kathleen Puntillo; E Wesley Ely; Céline Gélinas; Joseph F Dasta; Judy E Davidson; John W Devlin; John P Kress; Aaron M Joffe; Douglas B Coursin; Daniel L Herr; Avery Tung; Bryce R H Robinson; Dorrie K Fontaine; Michael A Ramsay; Richard R Riker; Curtis N Sessler; Brenda Pun; Yoanna Skrobik; Roman Jaeschke
Journal:  Crit Care Med       Date:  2013-01       Impact factor: 7.598
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.